Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Senti Biosciences ( (SNTI) ) has shared an update.
On January 31, 2025, the Consulting Agreement between Senti Biosciences, Inc. and Yvonne Li, the Interim Chief Financial Officer, expired. Subsequently, Ms. Li ceased to serve as the company’s principal financial and accounting officer. However, on February 5, 2025, a new consulting agreement was established, allowing Ms. Li to continue as a consultant to assist with the transition of her duties until March 31, 2025.
More about Senti Biosciences
YTD Price Performance: 17.06%
Average Trading Volume: 2,423,966
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $21.54M
For an in-depth examination of SNTI stock, go to TipRanks’ Stock Analysis page.